Enova International counsel sells 10,000 shares
The 10,000-share sale was executed in multiple trades priced from $183.15 to $183.73 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Enova International, Inc. General Counsel and Secretary Sean Rahilly exercised options for 10,000 common shares on October 29, 2026, at an exercise price of $20.73 per share, then sold 10,000 shares at a weighted average price of $183.2608 per share. The derivative position was reported as 5,000 shares following the transaction, and no Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR F2, F3, F4 | 10,000 | $0.00 | $0.00 |
| Exercise | Common stock, par value $0.00001 per share | 10,000 | $20.73 | $207K |
| Sale | Common stock, par value $0.00001 per share F1 | 10,000 | $183.2608 | $1.83M |
Footnotes (4)
- F1. This transaction was executed in multiple trades at prices ranging from $183.15 to $183.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- F2. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F3. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F4. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Key Figures
Key Terms
Non-Qualified Stock Option financial
limited stock appreciation right (SAR) financial
weighted average sale price financial
Change in Control financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ENVA options did Sean Rahilly exercise?
What price range did Sean Rahilly's ENVA stock sale cover?
AI-generated analysis. How Rhea-AI works. Not financial advice.